10-12-2023, 09:13 AM
Fenbendazole, primarily known as an anthelmintic for animals, has gained attention in recent years due to its potential as an anticancer drug. While preliminary studies and anecdotal reports suggest that fenbendazole may have anti-cancer properties, its use in cancer treatment is not well-established and is not approved by regulatory authorities. Research is ongoing to better understand its mechanisms and potential benefits in human cancer therapy. It's crucial to emphasize that patients should not self-administer fenbendazole for cancer treatment. Instead, individuals with cancer should rely on established and evidence-based treatments prescribed by oncologists to ensure their safety and well-being.